These emerging therapies , Tirzepatide , represent a significant advancement in managing metabolic dysfunction and possibly associated ailments . These drugs are classified as GLP-1 hormone https://mariyahadqn202980.pointblog.net/semaglutide-a-deep-examination-into-metabolic-agents-93397422